Controlled release of dopamine from a polymeric brain implant: In vitro characterization
暂无分享,去创建一个
[1] T. Kappe,et al. Ultraviolet Absorption Spectra and Apparent Acidic Dissociation Constants of Some Phenolic Amines1 , 1965 .
[2] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .
[3] R. Langer,et al. Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. , 1980, Journal of pharmaceutical sciences.
[4] R. Langer,et al. A NEW APPROACH TO ACHIEVE ZERO-ORDER RELEASE KINETICS FROM DIFFUSION-CONTROLLED POLYMER MATRIX SYSTEMS , 1980 .
[5] E. Frenkel,et al. Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors. , 1980, Neurosurgery.
[6] E. Frenkel,et al. Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[7] DIFFUSIONAL RELEASE OF WATER-SOLUBLE BIOACTIVE AGENTS FROM ETHYLENE-VINYL ACETATE COPOLYMERS , 1983 .
[8] D. Roberts,et al. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. , 1984, Neurosurgery.
[9] R. Langer,et al. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules. , 1984, Journal of pharmaceutical sciences.
[10] R. Langer,et al. An explanation for the controlled release of macromolecules from polymers , 1985 .
[11] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of biomedical materials research.
[12] G. Sedvall,et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. , 1985, Journal of neurosurgery.
[13] R Langer,et al. Controlled release and magnetically modulated release systems for macromolecules. , 1985, Methods in enzymology.
[14] Controlled Release of Insulin From Polymer Matrices: In Vitro Kinetics , 1986, Diabetes.
[15] E. Edelman,et al. Controlled Release of Insulin From Polymer Matrices: Control of Diabetes in Rats , 1986, Diabetes.
[16] W. Pardridge. Blood-brain barrier transport of nutrients. , 2009, Nutrition reviews.
[17] B. Blumenstein,et al. Malfunction of Continuous Subcutaneous Insulin Infusion Systems: A One-Year Prospective Study of 127 Patients , 1986, Diabetes Care.
[18] J. Nutt. On‐off phenomenon: Relation to levodopa pharmacokinetics and pharmacodynamics , 1987, Annals of neurology.
[19] D. Gash,et al. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. , 1987, Science.
[20] R. Joynt,et al. Neural transplants: Are we ready? , 1987, Annals of neurology.
[21] R. Drucker-Colín,et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. , 1987, The New England journal of medicine.
[22] O. Lindvall,et al. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen , 1987, Annals of neurology.
[23] R. Lewin. Dramatic results with brain grafts. , 1987, Science.
[24] J. Rosenstein. Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules. , 1987, Science.
[25] W. J. Freed,et al. Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra. , 1987, Life sciences.
[26] R. Wurtman,et al. Effects of systemicl-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens , 1988, Brain Research.
[27] Charles R.scriver,et al. The Metabolic basis of inherited disease , 1989 .
[28] R. Langer,et al. Transport rates of proteins in porous materials with known microgeometry. , 1989, Biophysical journal.
[29] A Deutch,et al. Controlled release of dopamine from a polymeric brain implant: In vivo characterization , 1989, Annals of neurology.